Gene Spotlight · Drug & Food Reactions

G6PD Deficiency: The World's Most Common Enzyme Disorder Hides in Plain Sight

Over 400 million people worldwide carry G6PD deficiency — and most have no idea, because it causes zero symptoms until a specific food, drug, or infection triggers a sudden hemolytic crisis. It may also be one of evolution's stranger bargains.

Gene Spotlights · 7 min read · Updated July 2026

Most genetic conditions are rare by definition. G6PD deficiency breaks that pattern completely — it's the most common enzyme deficiency in the world, and in some populations, it affects a genuinely staggering share of the population. Yet ask most people if they've heard of it, and the answer is usually no.

400M+
People worldwide are estimated to have G6PD deficiency, making it the most common human enzymopathy — more common than any single condition on a standard newborn screening panel.

What G6PD Actually Does

G6PD (glucose-6-phosphate dehydrogenase) is an enzyme found in every cell in your body, but its absence matters most in red blood cells. Its job is to help produce a molecule called NADPH, which red blood cells use as their primary defense against oxidative stress — the cellular damage caused by unstable molecules called reactive oxygen species. Red blood cells have no other backup system for this; unlike most other cells, they can't fall back on additional metabolic pathways when G6PD is missing.

When G6PD is deficient, red blood cells function completely normally under everyday conditions. The problem only appears when something floods the system with oxidative stress faster than the cell can handle without G6PD's protection — certain drugs, specific foods, or even an infection. When that happens, red blood cells rupture in large numbers, a process called hemolysis, and it can happen fast.

Why it's called "favism": The name comes from the fava bean — Vicia faba — which contains natural oxidant compounds that are harmless to most people but can trigger a severe hemolytic crisis in someone with G6PD deficiency, sometimes within hours of eating them. It's one of the only conditions in medicine named directly after the food that exposes it.

Where It's Most Common — And Why That's Not a Coincidence

15-26%
Parts of Sub-Saharan Africa
4-30%
Mediterranean populations
10-20%
Southeast Asia

The geographic pattern isn't random — it overlaps strikingly with regions that have historically had high rates of malaria. G6PD deficiency is X-linked, and research suggests it may have persisted at such high frequency because it offers some protection against severe malaria, similar to the better-known relationship between sickle cell trait and malaria resistance. It's a genetic trade-off: a measure of protection against one of history's deadliest diseases, in exchange for lifelong vulnerability to a specific list of triggers.

Because It's X-Linked, Sex Matters a Lot Here

The G6PD gene sits on the X chromosome. Since men have only one X chromosome, a single non-working copy is enough to cause deficiency — every male carrier is affected. Women have two X chromosomes, so they need two non-working copies to be fully deficient; women with just one non-working copy are typically unaffected or only mildly affected, though some experience intermediate symptoms due to a biological process called X-inactivation, where different cells in the body randomly "silence" one X chromosome or the other.

What Actually Triggers a Crisis

Fava beansThe classic trigger — can cause hemolysis within hours in sensitive individuals, especially children.
Certain antibioticsSulfa drugs and some others are well-documented triggers of hemolytic crisis in G6PD-deficient patients.
Antimalarial drugsPrimaquine, used to treat and prevent malaria, is a well-known trigger — creating a difficult irony given the gene's malaria-protective history.
Infections & illnessThe oxidative stress of a bacterial or viral infection alone can be enough to trigger hemolysis, even without any drug or food exposure.

Why This Matters More Than Most People Realize

G6PD status isn't just a curiosity — it directly affects real medical decisions. The World Health Organization recommends population-level screening in regions where male prevalence is 3-5% or higher, specifically because primaquine — one of the most effective antimalarial drugs available — can trigger dangerous hemolysis in deficient individuals, creating a genuine clinical dilemma in malaria treatment programs worldwide.

On an individual level, knowing your G6PD status means:

Find Out Before a Routine Prescription Becomes an Emergency

Dante Labs' whole genome sequencing captures your full G6PD gene status — one data point that can change what your doctor prescribes for the rest of your life.

Explore Whole Genome Sequencing →
Use code GENOME for 10% off
Sources: Wikipedia/WHO summary data on G6PD deficiency prevalence; PMC, "Glucose-6-phosphate dehydrogenase deficiency prevalence and genetic variants in malaria endemic areas of Colombia"; PMC, "Prevalence of Glucose-6-Phosphate Dehydrogenase Deficiency Among Children in Eastern Saudi Arabia"; World Health Organization G6PD screening guidance. This article is for educational purposes and is not a substitute for medical advice.